CAVADIS B V has a total of 14 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets measurement, pharmaceuticals and machines are ONCIMMUNE LTD, CYTOSIGNET INC and CIS BIOTECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | Australia | 1 | |
#6 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Pharmaceuticals | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Timmers Leonardus | 10 |
#2 | Sze Siu Kwan | 10 |
#3 | De Kleijn Dominicus Paschalis Victor | 8 |
#4 | Pasterkamp Gerard | 7 |
#5 | De Kleijn Dominique | 5 |
#6 | Van Der Spek Petrus Johannes | 2 |
#7 | Moll Franciscus Laurens | 2 |
#8 | Swagemakers Sigrid Maria Alice | 2 |
#9 | Alice Swagemakers Sigrid Maria | 1 |
#10 | Gerard Pasterkamp | 1 |
Publication | Filing date | Title |
---|---|---|
WO2013120995A1 | Exosomal biomarker for cardiovascular events in females | |
WO2012110253A2 | Exosomal biomarkers for predicting cardiovascular events | |
EP2676141A2 | Exosomal biomarkers for predicting cardiovascular events | |
WO2012126531A1 | Method for diagnosing acute coronary syndrome (acs) | |
WO2012110099A1 | Determination of exosomal biomarkers for predicting cardiovascular events | |
SG181963A1 | Determination of exosomel biomarkers for predicting cardiovascular events |